# AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE
> **ANDA206180** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2017-12-19
## Drug
- **FDA Application Number:** ANDA206180
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE
- **Generic name:** AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE
- **Active ingredients:** AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AUROBINDO PHARMA
- **Manufacturer:** Aurobindo Pharma Limited
- **First approval:** 2017-12-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206180)
---
*MORVS · CC0 1.0*